Literature DB >> 19486920

Nanotechnological applications for the treatment of neurodegenerative disorders.

Girish Modi1, Viness Pillay, Yahya E Choonara, Valence M K Ndesendo, Lisa C du Toit, Dinesh Naidoo.   

Abstract

Nanotechnology employs engineered materials or devices that interact with biological systems at a molecular level and could revolutionize the treatment of neurodegenerative disorders (NDs) by stimulating, responding to and interacting with target sites to induce physiological responses while minimizing side-effects. Conventional drug delivery systems do not provide adequate cyto-architecture restoration and connection patterns that are essential for functional recovery in NDs, due to limitations posed by the restrictive blood-brain barrier. This review article provides a concise incursion into the current and future applications of nano-enabled drug delivery systems for the treatment of NDs, in particular Alzheimer's and Parkinson's diseases, and explores the application of nanotechnology in clinical neuroscience to develop innovative therapeutic modalities for the treatment of NDs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486920     DOI: 10.1016/j.pneurobio.2009.05.002

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  29 in total

Review 1.  Industrial toxicants and Parkinson's disease.

Authors:  W Michael Caudle; Thomas S Guillot; Carlos R Lazo; Gary W Miller
Journal:  Neurotoxicology       Date:  2012-01-30       Impact factor: 4.294

Review 2.  Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.

Authors:  Sibel Bozdağ Pehlivan
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

Review 3.  Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.

Authors:  Shringika Soni; Rakesh Kumar Ruhela; Bikash Medhi
Journal:  Adv Pharm Bull       Date:  2016-09-25

4.  Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery.

Authors:  Yuan Yu; Zhiqing Pang; Wei Lu; Qi Yin; Huile Gao; Xinguo Jiang
Journal:  Pharm Res       Date:  2011-10-07       Impact factor: 4.200

Review 5.  Available and emerging treatments for Parkinson's disease: a review.

Authors:  Patrick Hickey; Mark Stacy
Journal:  Drug Des Devel Ther       Date:  2011-05-02       Impact factor: 4.162

6.  Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules.

Authors:  Rudimar L Frozza; Andressa Bernardi; Juliana B Hoppe; André B Meneghetti; Aline Matté; Ana M O Battastini; Adriana R Pohlmann; Sílvia S Guterres; Christianne Salbego
Journal:  Mol Neurobiol       Date:  2013-01-12       Impact factor: 5.590

Review 7.  Nanomedicine: a primer for surgeons.

Authors:  K K Y Wong; X L Liu
Journal:  Pediatr Surg Int       Date:  2012-08-15       Impact factor: 1.827

8.  Nanoplatforms for magnetic resonance imaging of cancer.

Authors:  Monika A Cywińska; Ireneusz P Grudziński; Andrzej Cieszanowski; Michał Bystrzejewski; Magdalena Popławska
Journal:  Pol J Radiol       Date:  2011-04

Review 9.  The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Arch Neurol       Date:  2011-03

Review 10.  Neurological disorders and therapeutics targeted to surmount the blood-brain barrier.

Authors:  Jagat R Kanwar; Bhasker Sriramoju; Rupinder K Kanwar
Journal:  Int J Nanomedicine       Date:  2012-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.